GO
Loading...

Enter multiple symbols separated by commas

Latest Video

Tracking Baidu's shift to O2O services

Alex Wong, director of asset management at Ample Capital, discusses Baidu's shift to online-to-offline (O2O) sales.

For TPP, this week is make or break: Pro

Deborah Elms, executive director at Asian Trade Centre, explains why this week is the best time to seal a deal for the Trans-Pacific Partnership (TPP) trade pact.

Go all in on China's A-shares, says this expert

Wong Kok Hoi, managing director & CIO of APS Asset Management in Singapore, says the driving forces of the bull market in China remain intact.

Delta to buy stake in China Eastern for $450M

Boyong Liu, equity research analyst at Jefferies, discusses Delta Air Lines' decision to purchase 3.55 percent of China Eastern Airlines.

Hong Kong's Jia Jia set to become world's oldest panda

CNBC speaks to Suzanne Gendron, executive director of zoological operation & education at Ocean Park, as the theme park gears up for the birthday party of giant panda Jia Jia, who turns 37 this summer.

China's yuan remains 'rock steady': StanChart

Callum Henderson, global head of FX research at Standard Chartered, says the yuan remains steady against the dollar on Tuesday after the central bank fixed its midpoint at a two-week high.

Recent PBOC policies are short-term fixes: Coutts

Slowing economic growth has prompted the People's Bank of China to roll out short-term measures, says Mark McFarland, global chief economist at Coutts.

Who's in the driver's seat for US markets?

While the market turmoil in China may have some influence, the Fed and earnings releases remain the key focus of U.S. markets, says JJ Kinahan, managing director at TDAmeritrade.

This is the top credit risk for Asian banks

Eugene Tarzimanov, VP and senior credit officer at Moody's Investors Service, explains why the unwinding of asset bubbles is the biggest risk for Asian banks in the months ahead, followed by China's slowdown.

China stocks may see a 'double-dip': Expert

With sentiment being extremely fragile, Chinese shares could see a double-dip, says Dickie Wong, executive director of Kingston Securities.

China in turmoil again: What will the PBOC do?

Vasu Menon, VP of Group Wealth Management at OCBC Bank, says the People's Bank of China (PBoC) could ease monetary policy further and "do whatever it takes" to prevent a stock market crash.

Not surprised by the plunge in China stocks: OCBC

Vasu Menon, VP of Group Wealth Management at OCBC Bank, says the 8.5 percent slump in Chinese stocks shouldn't come as a surprise following a sharp 16 percent rebound in the past 2-3 weeks.

Taiwan will join expanded ITA scheme: Official

Jen-Ni Yang, director-general of the Bureau of Foreign Trade, says Taiwan will join the expanded tariff elimination program, which is important for the island's economic growth.

Will Japan see a buoyant earnings season in Q2?

Japan is the only country in the world that's seeing positive earnings momentum, says Peter Boardman, MD at Tradewinds.

What fueled the panic in Chinese stocks?

Chinese stocks plunged on Monday due to margin calls and concerns that Beijing could withdraw market support, says Andrew Sullivan, managing director for sales trading at Haitong International Securities.

Weak Q3 guidance hurt Baidu shares: Expert

Henry Guo, managing director of China Internet & Media at Summit Research Partners, says Baidu's weak revenue guidance sent its stock tumbling in after-hours trading overnight.

USCC: For TPP talks, the end is in sight

Tami Overby, senior vice president for Asia at the U.S. Chamber of Commerce (USCC), explains her optimism about the long-delayed Trans-Pacific Partnership (TPP) trade pact.

US stocks to see a good second half in 2015?

Mark Eibel, investment strategist at Russell Investments, says the U.S. market is set up nicely for the second half of 2015, as consumers start benefiting from soft energy prices.

China's stock rout leaves small investors in despair

CNBC's Eunice Yoon speaks to Yang Cheng, a farmer from the remote town of Panzhihua in Southwest China, who saw his savings vanish into thin air amid the market meltdown last month.

Premature to say China's meltdown is over: Pro

Despite last month's steep correction, China remains one of the most highly leveraged stock markets, says Chris Konstantinos, director of international portfolio management at Riverfront Investment Group.

Amid China's rout, safe-haven assets shine: Pro

Mark Todd, director of fixed income at the National Australia Bank, says China's market plunge will drive "lots of volatility" in the short term, making Treasurys and government bonds the preferred assets.

Surprised by Teva's cash payment for Allergan Generics: Pro

Brian Gilmartin, portfolio manager at Trinity Asset Management, discusses the deal between Israel's Teva Pharmaceutical and Allergan's generic pharmaceuticals business.

Why it's hard to gauge China's stock rout

It is difficult to assess Beijing's market-saving measures, as the extent of leverage remains unknown due to the trading halts, says Ed Dempsey, chief investment officer at Pension Partners.

Cramer: Here's why you care about China

Jim Cramer thinks the stock market madness in China makes a bigger impact on your money than you might expect.

Cramer: We are China 7 Hours Ago
Cramer: We are China

Is the U.S. market hostage to China? Mad Money host Jim Cramer shares his final thoughts of the day on what China means for your money.

Cramer's shopping list for a pullback

Mad Money's Jim Cramer goes through his list of mine-resistant stocks to see if there are any bargains.

FANG alone can't save the market: Cramer

Mad Money host Jim Cramer says "FANG" is back, but it can't stave off the bears no matter how sharp it may be.

A receptionist works in the Baidu research and development center in Beijing.

The "Fast Money" traders give you 4 plays in the internet sector ahead of big earnings news.

Fast Money Final Trade: GMCR, DGX, JPM & X

The Fast Money traders share their final trades of the day.

Options Action: Expect pain for Pfizer?

Dissecting a bearish bet on Pfizer, with CNBC contributor Mike Khouw.

Contact Latest Video

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Top Video